Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease

Desiree Watson, Eduardo Castaño, Tyler A. Kokjohn, Yu Min Kuo, Yuri L Lyubchenko, David Pinsky, E. Sander Connolly, Chera Esh, Dean C. Luehrs, W. Blaine Stine, Linda M. Rowse, Mark R. Emmerling, Alex E. Roher

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) features, but senile plaque abundance does not always correlate directly with the degree of dementia exhibited by AD patients. The mechanism(s) and dynamics of Aβ fibril genesis and deposition remain obscure. Enhanced Aβ synthesis rates coupled with decreased degradative enzyme production and accumulating physical modifications that dampen proteolysis may all enhance amyloid deposit formation. Amyloid accumulation may indirectly exert the greatest pathologic effect on the brain vasculature by destroying smooth muscle cells and creating a cascade of negative impacts on cerebral blood flow. The most visible manifestation of amyloid dis-equilibrium could actually be a defense mechanism employed to avoid serious vascular wall degradation while the major toxic effects to the gray and white matter neurons are mediated by soluble oligomeric Aβ peptides with high β-sheet content. The recognition that dynamic soluble oligomeric Aβ pools exist in AD and are correlated to disease severity led to neurotoxicity and physical conformation studies. It is now recognized that the most basic soluble Aβ peptides are stable dimers with hydrophobic regions sequestered from the aqueous environment and are capable of higher order aggregations. Time course experiments employing a modified ELISA method able to detect Aβ oligomers revealed dynamic intermolecular interactions and additional experiments physically confirmed the presence of stable amyloid multimers. Amyloid peptides that are rich in β-sheet structure are capable of creating toxic membrane ion channels and a capacity to self-assemble as annular structures was confirmed in vitro using atomic force microscopy. Biochemical studies have established that soluble Aβ peptides perturb metabolic processes, provoke release of deleterious reactive compounds, reduce blood flow, induce mitochondrial apoptotic toxicity and inhibit angiogenesis. While there is no question that gross amyloid deposition does contribute to AD pathology, the destructive potential now associated with soluble Aβ suggests that treatment strategies that target these molecules may be efficacious in preventing some of the devastating effects of AD.

Original languageEnglish (US)
Pages (from-to)869-881
Number of pages13
JournalNeurological research
Volume27
Issue number8
DOIs
StatePublished - Dec 1 2005

Fingerprint

Amyloid
Alzheimer Disease
Amyloid Plaques
Peptides
Poisons
Ion Channels
Cerebrovascular Circulation
Atomic Force Microscopy
Defense Mechanisms
Proteolysis
Smooth Muscle Myocytes
Blood Vessels
Dementia
Enzyme-Linked Immunosorbent Assay
Pathology
Neurons
Brain
Enzymes
Therapeutics

Keywords

  • Alzheimer's disease
  • Atomic force microscopy
  • ELISA
  • Neurotoxicity
  • Oligomer
  • β-amyloid

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease. / Watson, Desiree; Castaño, Eduardo; Kokjohn, Tyler A.; Kuo, Yu Min; Lyubchenko, Yuri L; Pinsky, David; Connolly, E. Sander; Esh, Chera; Luehrs, Dean C.; Blaine Stine, W.; Rowse, Linda M.; Emmerling, Mark R.; Roher, Alex E.

In: Neurological research, Vol. 27, No. 8, 01.12.2005, p. 869-881.

Research output: Contribution to journalArticle

Watson, D, Castaño, E, Kokjohn, TA, Kuo, YM, Lyubchenko, YL, Pinsky, D, Connolly, ES, Esh, C, Luehrs, DC, Blaine Stine, W, Rowse, LM, Emmerling, MR & Roher, AE 2005, 'Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease', Neurological research, vol. 27, no. 8, pp. 869-881. https://doi.org/10.1179/016164105X49436
Watson, Desiree ; Castaño, Eduardo ; Kokjohn, Tyler A. ; Kuo, Yu Min ; Lyubchenko, Yuri L ; Pinsky, David ; Connolly, E. Sander ; Esh, Chera ; Luehrs, Dean C. ; Blaine Stine, W. ; Rowse, Linda M. ; Emmerling, Mark R. ; Roher, Alex E. / Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease. In: Neurological research. 2005 ; Vol. 27, No. 8. pp. 869-881.
@article{7ac0ba17bd974237b9af3520d9bf3672,
title = "Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease",
abstract = "Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) features, but senile plaque abundance does not always correlate directly with the degree of dementia exhibited by AD patients. The mechanism(s) and dynamics of Aβ fibril genesis and deposition remain obscure. Enhanced Aβ synthesis rates coupled with decreased degradative enzyme production and accumulating physical modifications that dampen proteolysis may all enhance amyloid deposit formation. Amyloid accumulation may indirectly exert the greatest pathologic effect on the brain vasculature by destroying smooth muscle cells and creating a cascade of negative impacts on cerebral blood flow. The most visible manifestation of amyloid dis-equilibrium could actually be a defense mechanism employed to avoid serious vascular wall degradation while the major toxic effects to the gray and white matter neurons are mediated by soluble oligomeric Aβ peptides with high β-sheet content. The recognition that dynamic soluble oligomeric Aβ pools exist in AD and are correlated to disease severity led to neurotoxicity and physical conformation studies. It is now recognized that the most basic soluble Aβ peptides are stable dimers with hydrophobic regions sequestered from the aqueous environment and are capable of higher order aggregations. Time course experiments employing a modified ELISA method able to detect Aβ oligomers revealed dynamic intermolecular interactions and additional experiments physically confirmed the presence of stable amyloid multimers. Amyloid peptides that are rich in β-sheet structure are capable of creating toxic membrane ion channels and a capacity to self-assemble as annular structures was confirmed in vitro using atomic force microscopy. Biochemical studies have established that soluble Aβ peptides perturb metabolic processes, provoke release of deleterious reactive compounds, reduce blood flow, induce mitochondrial apoptotic toxicity and inhibit angiogenesis. While there is no question that gross amyloid deposition does contribute to AD pathology, the destructive potential now associated with soluble Aβ suggests that treatment strategies that target these molecules may be efficacious in preventing some of the devastating effects of AD.",
keywords = "Alzheimer's disease, Atomic force microscopy, ELISA, Neurotoxicity, Oligomer, β-amyloid",
author = "Desiree Watson and Eduardo Casta{\~n}o and Kokjohn, {Tyler A.} and Kuo, {Yu Min} and Lyubchenko, {Yuri L} and David Pinsky and Connolly, {E. Sander} and Chera Esh and Luehrs, {Dean C.} and {Blaine Stine}, W. and Rowse, {Linda M.} and Emmerling, {Mark R.} and Roher, {Alex E.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1179/016164105X49436",
language = "English (US)",
volume = "27",
pages = "869--881",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "8",

}

TY - JOUR

T1 - Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease

AU - Watson, Desiree

AU - Castaño, Eduardo

AU - Kokjohn, Tyler A.

AU - Kuo, Yu Min

AU - Lyubchenko, Yuri L

AU - Pinsky, David

AU - Connolly, E. Sander

AU - Esh, Chera

AU - Luehrs, Dean C.

AU - Blaine Stine, W.

AU - Rowse, Linda M.

AU - Emmerling, Mark R.

AU - Roher, Alex E.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) features, but senile plaque abundance does not always correlate directly with the degree of dementia exhibited by AD patients. The mechanism(s) and dynamics of Aβ fibril genesis and deposition remain obscure. Enhanced Aβ synthesis rates coupled with decreased degradative enzyme production and accumulating physical modifications that dampen proteolysis may all enhance amyloid deposit formation. Amyloid accumulation may indirectly exert the greatest pathologic effect on the brain vasculature by destroying smooth muscle cells and creating a cascade of negative impacts on cerebral blood flow. The most visible manifestation of amyloid dis-equilibrium could actually be a defense mechanism employed to avoid serious vascular wall degradation while the major toxic effects to the gray and white matter neurons are mediated by soluble oligomeric Aβ peptides with high β-sheet content. The recognition that dynamic soluble oligomeric Aβ pools exist in AD and are correlated to disease severity led to neurotoxicity and physical conformation studies. It is now recognized that the most basic soluble Aβ peptides are stable dimers with hydrophobic regions sequestered from the aqueous environment and are capable of higher order aggregations. Time course experiments employing a modified ELISA method able to detect Aβ oligomers revealed dynamic intermolecular interactions and additional experiments physically confirmed the presence of stable amyloid multimers. Amyloid peptides that are rich in β-sheet structure are capable of creating toxic membrane ion channels and a capacity to self-assemble as annular structures was confirmed in vitro using atomic force microscopy. Biochemical studies have established that soluble Aβ peptides perturb metabolic processes, provoke release of deleterious reactive compounds, reduce blood flow, induce mitochondrial apoptotic toxicity and inhibit angiogenesis. While there is no question that gross amyloid deposition does contribute to AD pathology, the destructive potential now associated with soluble Aβ suggests that treatment strategies that target these molecules may be efficacious in preventing some of the devastating effects of AD.

AB - Extracellular fibrillar amyloid deposits are prominent and universal Alzheimer's disease (AD) features, but senile plaque abundance does not always correlate directly with the degree of dementia exhibited by AD patients. The mechanism(s) and dynamics of Aβ fibril genesis and deposition remain obscure. Enhanced Aβ synthesis rates coupled with decreased degradative enzyme production and accumulating physical modifications that dampen proteolysis may all enhance amyloid deposit formation. Amyloid accumulation may indirectly exert the greatest pathologic effect on the brain vasculature by destroying smooth muscle cells and creating a cascade of negative impacts on cerebral blood flow. The most visible manifestation of amyloid dis-equilibrium could actually be a defense mechanism employed to avoid serious vascular wall degradation while the major toxic effects to the gray and white matter neurons are mediated by soluble oligomeric Aβ peptides with high β-sheet content. The recognition that dynamic soluble oligomeric Aβ pools exist in AD and are correlated to disease severity led to neurotoxicity and physical conformation studies. It is now recognized that the most basic soluble Aβ peptides are stable dimers with hydrophobic regions sequestered from the aqueous environment and are capable of higher order aggregations. Time course experiments employing a modified ELISA method able to detect Aβ oligomers revealed dynamic intermolecular interactions and additional experiments physically confirmed the presence of stable amyloid multimers. Amyloid peptides that are rich in β-sheet structure are capable of creating toxic membrane ion channels and a capacity to self-assemble as annular structures was confirmed in vitro using atomic force microscopy. Biochemical studies have established that soluble Aβ peptides perturb metabolic processes, provoke release of deleterious reactive compounds, reduce blood flow, induce mitochondrial apoptotic toxicity and inhibit angiogenesis. While there is no question that gross amyloid deposition does contribute to AD pathology, the destructive potential now associated with soluble Aβ suggests that treatment strategies that target these molecules may be efficacious in preventing some of the devastating effects of AD.

KW - Alzheimer's disease

KW - Atomic force microscopy

KW - ELISA

KW - Neurotoxicity

KW - Oligomer

KW - β-amyloid

UR - http://www.scopus.com/inward/record.url?scp=29044443820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29044443820&partnerID=8YFLogxK

U2 - 10.1179/016164105X49436

DO - 10.1179/016164105X49436

M3 - Article

C2 - 16354549

AN - SCOPUS:29044443820

VL - 27

SP - 869

EP - 881

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 8

ER -